Digitisation | April 19, 2024
Dr. Reddy’s launches integrated care plan to manage irritable bowel syndrome
Around 7% of the Indian population suffers from IBS
Around 7% of the Indian population suffers from IBS
Biocon will undertake the development, manufacturing and supply of the drug product, and Biomm will be responsible for obtaining regulatory approval and commercialization in the Brazilian market
The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility
TriClip offers a remarkably safe, minimally invasive treatment option for patients in need of tricuspid valve repair but who are unable to withstand surgery
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
The surgeons were able to remove the entire breast while preserving the nipple through tiny hidden incisions
India is contributing 13% to the global asthma burden and a disproportionate 43% of the global asthma deaths.
Acquisition of exclusive commercialization rights for European markets
Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
Subscribe To Our Newsletter & Stay Updated
